Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | THRB | P10828 | 1/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | CD69 | Q07108 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | PYGB | P11216 | 1/20 | 0.45 |
| ▸ | MMP12 | P39900 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25518922 | 1.00 | ALDH1A1 (0.63) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL14051305 | 1.00 | ALDH1A1 (0.63) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL9914082 | 1.00 | ALDH1A1 (0.63) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL14025370 | 1.00 | ALDH1A1 (0.63) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL22311649 | 1.00 | ALDH1A1 (0.63) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL11946954 | 1.00 | ALDH1A1 (0.63) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL18708293 | 1.00 | ALDH1A1 (0.63) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL22311199 | 1.00 | ALDH1A1 (0.63) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL22311210 | 1.00 | ALDH1A1 (0.63) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL9914084 | 0.89 | ALDH1A1 (0.57) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11780872-B2 | Oligosaccharide analytical standards | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2023-10-10 | — | — | US | disclosed |
| US-11739122-B2 | Glycopeptide antibiotic compounds, methods for producing the same, and uses thereof | ACADEMIA SINICA (TW) | 2023-08-29 | — | — | US | disclosed |
| US-20220169790-A1 | CARBOHYDRATE LIGANDS THAT BIND TO ANTIBODIES AGAINST GLYCOEPITOPES OF GLYCOSPHINGOLIPIDS | UNIV BASEL (CH) | 2022-06-02 | — | — | US | disclosed |
| US-11214588-B2 | Synthesis of oligosaccharides | GLYCOM A/S (DK) | 2022-01-04 | — | — | US | disclosed |
| US-11142541-B2 | Purification of oligosaccharides | GLYCOM A/S (DK) | 2021-10-12 | — | — | US | disclosed |
| US-20210198284-A1 | GOLD COMPOSITIONS AND METHODS OF USE THEREOF | UNIVERSITY OF MASSACHUSETTS | 2021-07-01 | — | — | US | disclosed |
| US-20210171562-A1 | OLIGOSACCHARIDE ANALYTICAL STANDARDS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-06-10 | — | — | US | disclosed |
| US-20200297693-A1 | GLUCOSE CONJUGATES OF TRIPTOLIDE, ANALOGS AND USES THEREOF | THE JOHNS HOPKINS UNIVERSITY | 2020-09-24 | — | — | US | disclosed |
| US-20200291071-A1 | GLYCOPEPTIDE COMPOUNDS, METHODS FOR PRODUCING THE SAME, AND USES THEREOF | ACADEMIA SINICA (TW) | 2020-09-17 | — | — | US | disclosed |
| WO-2020159448-A1 | MOLECULAR RENAL PROBES FOR DETECTING ACUTE KIDNEY INJURY | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2020-08-06 | — | — | WO | disclosed |
| US-20200215486-A1 | SYNTHESIS OF OLIGOSACCHARIDES | GLYCOM A/S (DK) | 2020-07-09 | — | — | US | disclosed |
| US-10695319-B2 | Glucose conjugates of triptolide, analogs and uses thereof | THE JOHNS HOPKINS UNIVERSITY (US) | 2020-06-30 | — | — | US | disclosed |
| US-20200148793-A1 | PURIFICATION OF OLIGOSACCHARIDES | GLYCOM A/S (DK) | 2020-05-14 | — | — | US | disclosed |
| US-20200123184-A1 | PURIFICATION OF OLIGOSACCHARIDES | GLYCOM A/S (DK) | 2020-04-23 | — | — | US | disclosed |
| WO-2016152980-A1 | OLIGONUCLEOTIDE DERIVATIVE, OLIGONUCLEOTIDE CONSTRUCT USING SAME, AND METHODS FOR PRODUCING THESE | 国立大学法人岐阜大学 | 2016-09-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11780872-B2 | Oligosaccharide analytical standards | OSTC, FUT5, FUT6 | ALDH1A1 2232/4885THRB 1476/4885MAPK1 3330/4885 |
| US-20200123184-A1 | PURIFICATION OF OLIGOSACCHARIDES | FUT5, FUT6, LCT | ALDH1A1 2010/4885THRB 1941/4885MAPK1 3803/4885 |
| US-11142541-B2 | Purification of oligosaccharides | OSTC, FUT5, FUT6 | ALDH1A1 3625/4885THRB 3849/4885MAPK1 4292/4885 |
| US-20210198284-A1 | GOLD COMPOSITIONS AND METHODS OF USE THEREOF | LSS, LGALS7; LGALS7B, LGALS3 | ALDH1A1 493/4885THRB 4449/4885MAPK1 4566/4885 |
| US-20200297693-A1 | GLUCOSE CONJUGATES OF TRIPTOLIDE, ANALOGS AND USES THEREOF | SLC2A8, SLC2A4, SLC2A1 | ALDH1A1 1107/4885THRB 1074/4885MAPK1 1645/4885 |
| US-20210171562-A1 | OLIGOSACCHARIDE ANALYTICAL STANDARDS | OSTC, FUT5, FUT6 | ALDH1A1 2232/4885THRB 1476/4885MAPK1 3330/4885 |
| US-11214588-B2 | Synthesis of oligosaccharides | MGAM, LCT, LPO | ALDH1A1 3246/4885THRB 2943/4885MAPK1 3696/4885 |
| US-20200291071-A1 | GLYCOPEPTIDE COMPOUNDS, METHODS FOR PRODUCING THE SAME, AND USES THEREOF | B3GAT3, MGAM, GALNT14 | ALDH1A1 3371/4885THRB 2039/4885MAPK1 3577/4885 |
| US-10695319-B2 | Glucose conjugates of triptolide, analogs and uses thereof | SLC2A8, SLC2A4, SLC2A1 | ALDH1A1 1107/4885THRB 1074/4885MAPK1 1645/4885 |
| US-11739122-B2 | Glycopeptide antibiotic compounds, methods for producing the same, and uses thereof | NGLY1, NRDC, MGAT3 | ALDH1A1 3782/4885THRB 128/4885MAPK1 2346/4885 |
| US-20220169790-A1 | CARBOHYDRATE LIGANDS THAT BIND TO ANTIBODIES AGAINST GLYCOEPITOPES OF GLYCOSPHINGOLIPIDS | SIGLEC7, GALC, GBA1 | ALDH1A1 2449/4885THRB 2336/4885MAPK1 3057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.